Trial Profile
Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary)
- Indications Sickle cell anaemia
- Focus Adverse reactions; Therapeutic Use
- 23 Jan 2018 Status changed from recruiting to completed.
- 12 Jan 2017 Status changed from not yet recruiting to recruiting.
- 15 Dec 2016 New trial record